ID   P55G_HUMAN              Reviewed;         461 AA.
AC   Q92569; B2R9C1; D3DQ12; O60482; Q5T4P1; Q5T4P2;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 2.
DT   10-MAY-2017, entry version 157.
DE   RecName: Full=Phosphatidylinositol 3-kinase regulatory subunit gamma;
DE            Short=PI3-kinase regulatory subunit gamma;
DE            Short=PI3K regulatory subunit gamma;
DE            Short=PtdIns-3-kinase regulatory subunit gamma;
DE   AltName: Full=Phosphatidylinositol 3-kinase 55 kDa regulatory subunit gamma;
DE            Short=PI3-kinase subunit p55-gamma;
DE            Short=PtdIns-3-kinase regulatory subunit p55-gamma;
DE   AltName: Full=p55PIK;
GN   Name=PIK3R3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3), AND VARIANT LYS-283.
RC   TISSUE=Fetal brain;
RX   PubMed=9524259; DOI=10.1016/S0378-1119(98)00045-6;
RA   Dey B.R., Furlanetto R.W., Nissley S.P.;
RT   "Cloning of human p55 gamma, a regulatory subunit of
RT   phosphatidylinositol 3-kinase, by a yeast two-hybrid library screen
RT   with the insulin-like growth factor-I receptor.";
RL   Gene 209:175-183(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT LYS-283.
RA   Suzuki T.;
RT   "Molecular cloning of human p55pik.";
RL   Submitted (OCT-1996) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   LYS-283.
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT LYS-283.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   INTERACTION WITH AXL.
RX   PubMed=12470648; DOI=10.1016/S0006-291X(02)02718-3;
RA   Hafizi S., Alindri F., Karlsson R., Dahlbaeck B.;
RT   "Interaction of Axl receptor tyrosine kinase with C1-TEN, a novel C1
RT   domain-containing protein with homology to tensin.";
RL   Biochem. Biophys. Res. Commun. 299:793-800(2002).
CC   -!- FUNCTION: Binds to activated (phosphorylated) protein-tyrosine
CC       kinases through its SH2 domain and regulates their kinase
CC       activity. During insulin stimulation, it also binds to IRS-1.
CC   -!- SUBUNIT: Heterodimer of a regulatory subunit PIK3R3 and a p110
CC       catalytic subunit (PIK3CA, PIK3CB or PIK3CD). Interacts with AXL.
CC       {ECO:0000269|PubMed:12470648}.
CC   -!- INTERACTION:
CC       Q8IZP0:ABI1; NbExp=2; IntAct=EBI-79893, EBI-375446;
CC       P10275:AR; NbExp=37; IntAct=EBI-79893, EBI-608057;
CC       Q66PJ3-4:ARL6IP4; NbExp=3; IntAct=EBI-79893, EBI-5280499;
CC       P22681:CBL; NbExp=4; IntAct=EBI-79893, EBI-518228;
CC       Q96LK0:CEP19; NbExp=3; IntAct=EBI-79893, EBI-741885;
CC       P46108:CRK; NbExp=3; IntAct=EBI-79893, EBI-886;
CC       P53672:CRYBA2; NbExp=4; IntAct=EBI-79893, EBI-750444;
CC       P00533:EGFR; NbExp=6; IntAct=EBI-79893, EBI-297353;
CC       P04626:ERBB2; NbExp=9; IntAct=EBI-79893, EBI-641062;
CC       P21860:ERBB3; NbExp=22; IntAct=EBI-79893, EBI-720706;
CC       O43559:FRS3; NbExp=3; IntAct=EBI-79893, EBI-725515;
CC       Q13480:GAB1; NbExp=36; IntAct=EBI-79893, EBI-517684;
CC       P08631-2:HCK; NbExp=4; IntAct=EBI-79893, EBI-9834454;
CC       P42858:HTT; NbExp=6; IntAct=EBI-79893, EBI-466029;
CC       P35568:IRS1; NbExp=4; IntAct=EBI-79893, EBI-517592;
CC       P10721:KIT; NbExp=31; IntAct=EBI-79893, EBI-1379503;
CC       P08581:MET; NbExp=11; IntAct=EBI-79893, EBI-1039152;
CC       Q8TAK6:OLIG1; NbExp=2; IntAct=EBI-79893, EBI-3867416;
CC       Q6GQQ9:OTUD7B; NbExp=3; IntAct=EBI-79893, EBI-527784;
CC       Q9NPB6-2:PARD6A; NbExp=3; IntAct=EBI-79893, EBI-10693102;
CC       Q8N2H9:PELI3; NbExp=3; IntAct=EBI-79893, EBI-448457;
CC       P42336:PIK3CA; NbExp=4; IntAct=EBI-79893, EBI-2116585;
CC       Q5SXH7:PLEKHS1; NbExp=5; IntAct=EBI-79893, EBI-10691507;
CC       O60237-2:PPP1R12B; NbExp=2; IntAct=EBI-79893, EBI-10700351;
CC       Q05397:PTK2; NbExp=3; IntAct=EBI-79893, EBI-702142;
CC       Q96R05:RBP7; NbExp=3; IntAct=EBI-79893, EBI-2856326;
CC       Q9NP31:SH2D2A; NbExp=4; IntAct=EBI-79893, EBI-490630;
CC       Q8WXH5:SOCS4; NbExp=3; IntAct=EBI-79893, EBI-3942425;
CC       Q99619:SPSB2; NbExp=3; IntAct=EBI-79893, EBI-2323209;
CC       P12931:SRC; NbExp=3; IntAct=EBI-79893, EBI-621482;
CC       O60636:TSPAN2; NbExp=3; IntAct=EBI-79893, EBI-3914288;
CC       Q8N6F8:WBSCR27; NbExp=3; IntAct=EBI-79893, EBI-8487781;
CC       Q8IZQ1:WDFY3; NbExp=2; IntAct=EBI-79893, EBI-1569256;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q92569-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q92569-2; Sequence=VSP_004714;
CC       Name=3;
CC         IsoId=Q92569-3; Sequence=VSP_004713, VSP_004714;
CC   -!- TISSUE SPECIFICITY: Highest levels in brain and testis. Lower
CC       levels in adipose tissue, kidney, heart, lung and skeletal muscle.
CC   -!- SIMILARITY: Belongs to the PI3K p85 subunit family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF028785; AAC39696.1; -; mRNA.
DR   EMBL; D88532; BAA13636.1; -; mRNA.
DR   EMBL; AK313726; BAG36468.1; -; mRNA.
DR   EMBL; AL358075; CAI21702.1; -; Genomic_DNA.
DR   EMBL; AL358075; CAI21703.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX06946.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX06947.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX06944.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX06945.1; -; Genomic_DNA.
DR   CCDS; CCDS529.1; -. [Q92569-1]
DR   CCDS; CCDS76154.1; -. [Q92569-2]
DR   RefSeq; NP_001107644.1; NM_001114172.1. [Q92569-1]
DR   RefSeq; NP_001290358.1; NM_001303429.1. [Q92569-2]
DR   RefSeq; NP_003620.3; NM_003629.3. [Q92569-1]
DR   RefSeq; XP_016858103.1; XM_017002614.1. [Q92569-1]
DR   UniGene; Hs.655387; -.
DR   ProteinModelPortal; Q92569; -.
DR   SMR; Q92569; -.
DR   BioGrid; 114075; 117.
DR   DIP; DIP-30925N; -.
DR   IntAct; Q92569; 131.
DR   MINT; MINT-1490763; -.
DR   STRING; 9606.ENSP00000262741; -.
DR   ChEMBL; CHEMBL3559703; -.
DR   DrugBank; DB01064; Isoprenaline.
DR   DrugBank; DB05210; SF1126.
DR   iPTMnet; Q92569; -.
DR   PhosphoSitePlus; Q92569; -.
DR   BioMuta; PIK3R3; -.
DR   DMDM; 317373310; -.
DR   EPD; Q92569; -.
DR   MaxQB; Q92569; -.
DR   PaxDb; Q92569; -.
DR   PeptideAtlas; Q92569; -.
DR   PRIDE; Q92569; -.
DR   DNASU; 8503; -.
DR   Ensembl; ENST00000262741; ENSP00000262741; ENSG00000117461. [Q92569-1]
DR   Ensembl; ENST00000372006; ENSP00000361075; ENSG00000117461. [Q92569-1]
DR   Ensembl; ENST00000420542; ENSP00000412546; ENSG00000117461. [Q92569-1]
DR   Ensembl; ENST00000423209; ENSP00000391431; ENSG00000117461. [Q92569-2]
DR   GeneID; 8503; -.
DR   KEGG; hsa:8503; -.
DR   UCSC; uc001cpb.5; human. [Q92569-1]
DR   CTD; 8503; -.
DR   DisGeNET; 8503; -.
DR   GeneCards; PIK3R3; -.
DR   H-InvDB; HIX0000542; -.
DR   HGNC; HGNC:8981; PIK3R3.
DR   HPA; HPA005751; -.
DR   HPA; HPA071988; -.
DR   MIM; 606076; gene.
DR   neXtProt; NX_Q92569; -.
DR   OpenTargets; ENSG00000117461; -.
DR   PharmGKB; PA33314; -.
DR   eggNOG; KOG4637; Eukaryota.
DR   eggNOG; ENOG410XP6R; LUCA.
DR   GeneTree; ENSGT00390000010431; -.
DR   HOVERGEN; HBG082100; -.
DR   InParanoid; Q92569; -.
DR   KO; K02649; -.
DR   OrthoDB; EOG091G0C3Z; -.
DR   PhylomeDB; Q92569; -.
DR   TreeFam; TF102033; -.
DR   BioCyc; MetaCyc:ENSG00000117461-MONOMER; -.
DR   Reactome; R-HSA-114604; GPVI-mediated activation cascade.
DR   Reactome; R-HSA-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-HSA-1266695; Interleukin-7 signaling.
DR   Reactome; R-HSA-1433557; Signaling by SCF-KIT.
DR   Reactome; R-HSA-1660499; Synthesis of PIPs at the plasma membrane.
DR   Reactome; R-HSA-2219530; Constitutive Signaling by Aberrant PI3K in Cancer.
DR   Reactome; R-HSA-388841; Costimulation by the CD28 family.
DR   Reactome; R-HSA-389357; CD28 dependent PI3K/Akt signaling.
DR   Reactome; R-HSA-392451; G beta:gamma signalling through PI3Kgamma.
DR   Reactome; R-HSA-416476; G alpha (q) signalling events.
DR   Reactome; R-HSA-416482; G alpha (12/13) signalling events.
DR   Reactome; R-HSA-512988; Interleukin-3, 5 and GM-CSF signaling.
DR   Reactome; R-HSA-6811558; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling.
DR   Reactome; R-HSA-8853659; RET signaling.
DR   Reactome; R-HSA-912526; Interleukin receptor SHC signaling.
DR   Reactome; R-HSA-912631; Regulation of signaling by CBL.
DR   SignaLink; Q92569; -.
DR   SIGNOR; Q92569; -.
DR   ChiTaRS; PIK3R3; human.
DR   GeneWiki; PIK3R3; -.
DR   GenomeRNAi; 8503; -.
DR   PRO; PR:Q92569; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000117461; -.
DR   CleanEx; HS_PIK3R3; -.
DR   ExpressionAtlas; Q92569; baseline and differential.
DR   Genevisible; Q92569; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005942; C:phosphatidylinositol 3-kinase complex; IBA:GO_Central.
DR   GO; GO:0016303; F:1-phosphatidylinositol-3-kinase activity; TAS:ProtInc.
DR   GO; GO:0046935; F:1-phosphatidylinositol-3-kinase regulator activity; IBA:GO_Central.
DR   GO; GO:0001784; F:phosphotyrosine binding; IPI:CAFA.
DR   GO; GO:0008286; P:insulin receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome.
DR   GO; GO:2001275; P:positive regulation of glucose import in response to insulin stimulus; ISS:AgBase.
DR   GO; GO:0043551; P:regulation of phosphatidylinositol 3-kinase activity; IBA:GO_Central.
DR   Gene3D; 3.30.505.10; -; 2.
DR   InterPro; IPR032498; PI3K_P85_iSH2.
DR   InterPro; IPR001720; PI3kinase_P85.
DR   InterPro; IPR000980; SH2.
DR   PANTHER; PTHR10155; PTHR10155; 1.
DR   Pfam; PF16454; PI3K_P85_iSH2; 1.
DR   Pfam; PF00017; SH2; 2.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   SMART; SM00252; SH2; 2.
DR   SUPFAM; SSF55550; SSF55550; 2.
DR   PROSITE; PS50001; SH2; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; SH2 domain.
FT   CHAIN         1    461       Phosphatidylinositol 3-kinase regulatory
FT                                subunit gamma.
FT                                /FTId=PRO_0000080767.
FT   DOMAIN       65    160       SH2 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00191}.
FT   DOMAIN      358    452       SH2 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00191}.
FT   COMPBIAS     34     44       Pro-rich.
FT   MOD_RES     341    341       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q64143}.
FT   VAR_SEQ      36     71       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:9524259}.
FT                                /FTId=VSP_004713.
FT   VAR_SEQ     256    314       Missing (in isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:9524259}.
FT                                /FTId=VSP_004714.
FT   VARIANT     283    283       N -> K (in dbSNP:rs785467).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:9524259,
FT                                ECO:0000269|Ref.2, ECO:0000269|Ref.5}.
FT                                /FTId=VAR_047153.
FT   CONFLICT     21     21       P -> L (in Ref. 1; AAC39696).
FT                                {ECO:0000305}.
SQ   SEQUENCE   461 AA;  54448 MW;  303BCC2F9EEE5364 CRC64;
     MYNTVWSMDR DDADWREVMM PYSTELIFYI EMDPPALPPK PPKPMTSAVP NGMKDSSVSL
     QDAEWYWGDI SREEVNDKLR DMPDGTFLVR DASTKMQGDY TLTLRKGGNN KLIKIYHRDG
     KYGFSDPLTF NSVVELINHY HHESLAQYNP KLDVKLMYPV SRYQQDQLVK EDNIDAVGKK
     LQEYHSQYQE KSKEYDRLYE EYTRTSQEIQ MKRTAIEAFN ETIKIFEEQC HTQEQHSKEY
     IERFRREGNE KEIERIMMNY DKLKSRLGEI HDSKMRLEQD LKNQALDNRE IDKKMNSIKP
     DLIQLRKIRD QHLVWLNHKG VRQKRLNVWL GIKNEDADEN YFINEEDENL PHYDEKTWFV
     EDINRVQAED LLYGKPDGAF LIRESSKKGC YACSVVADGE VKHCVIYSTA RGYGFAEPYN
     LYSSLKELVL HYQQTSLVQH NDSLNVRLAY PVHAQMPSLC R
//
